These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21153190)

  • 1. Complement action on secretory cells identified by the reverse hemolytic plaque assay: modified assay eliminates exposure of secretory cells to complement.
    Gregerson KA
    Endocrine; 1995 May; 3(5):371-6. PubMed ID: 21153190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation of the reverse hemolytic plaque assay to electron microscopy: a study of the individual secretory activity in prolactin cell subpopulations.
    Vila-Porcile E; Picart R; Tougard C
    J Histochem Cytochem; 1994 Jan; 42(1):11-22. PubMed ID: 8263322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-function correlations of growth hormone or/and prolactin-producing pituitary adenomas: an in vitro study with the reverse hemolytic plaque assay.
    Thodou E; Kontogeorgos G; Kyrodimou E; Salla H; Ramyar L; Vamvassakis E; Piaditis G; Anagnostopoulos N; Tzanis S; Levedis A; Rologis D; Asa SL
    J Endocrinol Invest; 1999 Oct; 22(9):671-80. PubMed ID: 10595830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual parathyroid cells exhibit cyclic secretion of parathyroid hormone and chromogranin-A (as measured by a novel sequential hemolytic plaque assay).
    Ritchie CK; Cohn DV; Maercklein PB; Fitzpatrick LA
    Endocrinology; 1992 Dec; 131(6):2638-42. PubMed ID: 1446605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stimulatory and inhibitory effects of dopamine on prolactin secretion involve different G-proteins.
    Burris TP; Nguyen DN; Smith SG; Freeman ME
    Endocrinology; 1992 Feb; 130(2):926-32. PubMed ID: 1733734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of hormone release from individual cells in mixed populations using a reverse hemolytic plaque assay.
    Neill JD; Frawley LS
    Endocrinology; 1983 Mar; 112(3):1135-7. PubMed ID: 6401620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effect of basic fibroblast growth factor on secretion of prolactin as assessed by the reverse hemolytic plaque assay.
    Larson GH; Koos RD; Sortino MA; Wise PM
    Endocrinology; 1990 Feb; 126(2):927-32. PubMed ID: 2105207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the reverse hemolytic plaque assay to study the regulation of anterior lobe adrenocorticotropin (ACTH) secretion by ACTH-releasing factor, arginine vasopressin, angiotensin II, and glucocorticoids.
    Childs GV; Burke JA
    Endocrinology; 1987 Feb; 120(2):439-44. PubMed ID: 3026776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subpopulations of lactotropes detected with the reverse hemolytic plaque assay show differential responsiveness to dopamine.
    Luque EH; Munoz de Toro M; Smith PF; Neill JD
    Endocrinology; 1986 May; 118(5):2120-4. PubMed ID: 3084212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A diffusion-adsorption model for the computation of the amount of hormone around a secreting cell, detected by the reverse hemolytic plaque assay.
    Allaerts W; Wouters A; Van der Massen D; Persoons A; Denef C
    J Theor Biol; 1988 Apr; 131(4):441-59. PubMed ID: 3057286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hyperprolactinemia on luteinizing hormone and prolactin secretion assessed using the reverse hemolytic plaque assay.
    Sortino MA; Wise PM
    Biol Reprod; 1989 Oct; 41(4):618-25. PubMed ID: 2695175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of relaxin release by cultured porcine luteal cells using a reverse hemolytic plaque assay: effects of arachidonic acid, cyclo- and lipooxygenase blockers, phospholipase A2, and melittin.
    Taylor MJ; Clark CL
    Endocrinology; 1989 Sep; 125(3):1389-97. PubMed ID: 2503367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverse hemolytic plaque assays: versatility in the study of secretion.
    Boockfor FR; Fidan M
    Methods; 2004 Aug; 33(4):273-80. PubMed ID: 15183175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related alterations in prolactin secretion by individual cells as assessed by the reverse hemolytic plaque assay.
    Larson GH; Wise PM
    Biol Reprod; 1991 Apr; 44(4):648-55. PubMed ID: 1904281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of prolactin and growth hormone production in the MtT/F4 transplantable pituitary tumor by the reverse hemolytic plaque assay.
    Lloyd RV
    Am J Pathol; 1987 Dec; 129(3):441-7. PubMed ID: 3322022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of growth hormone release from rat anterior pituitary cells by reverse hemolytic plaque assay: influence of interleukin-1.
    Niimi M; Sato M; Wada Y; Tamaki M; Takahara J; Kawanishi K
    Life Sci; 1994; 55(23):1807-13. PubMed ID: 7968261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensinogen secretion by single rat pituitary cells: detection by a reverse haemolytic plaque assay and cell identification by immunocytochemistry.
    Sernia C; Shinkel TA; Thomas WG; Ho KK; Lincoln D
    Neuroendocrinology; 1992 Mar; 55(3):308-16. PubMed ID: 1501759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone secretion by normal human parathyroid cells in vitro: characterization by the reverse hemolytic plaque assay.
    Herrera MF; Grant CS; Maercklein P; van Heerden JA; Fitzpatrick LA
    Surgery; 1993 Apr; 113(4):410-8. PubMed ID: 8456397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of excitatory amino acid receptor agonists on secretion of growth hormone as assessed by the reverse hemolytic plaque assay.
    Niimi M; Sato M; Murao K; Takahara J; Kawanishi K
    Neuroendocrinology; 1994 Aug; 60(2):173-8. PubMed ID: 7969775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian steroids modulate responsiveness to dopamine and expression of G-proteins in lactotropes.
    Livingstone JD; Lerant A; Freeman ME
    Neuroendocrinology; 1998 Sep; 68(3):172-9. PubMed ID: 9734001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.